Report cover image

Middle East and Africa Veterinary Vaccines Market, By Type (Poultry Vaccine, Livestock Vaccines (Bovine Vaccines, Small Ruminant Vaccines); Companion Animal Vaccines (Feline Vaccines, Canine Vaccines), Aquaculture Vaccine); By Technology (Live Attenuated

Publisher BlueWeave Consulting
Published Jan 30, 2024
Length 200 Pages
SKU # BLWC18529297

Description

Middle East and Africa Veterinary Vaccines Market Size Expands at CAGR of 5.42% to Cross USD 648 Million by 2030

Middle East and Africa Veterinary Vaccines Market is propelled by growing awareness about animal health, increasing pet ownership, rising incidence of zoonotic diseases, government initiatives for animal vaccination, and advancements in veterinary healthcare.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Middle East and Africa Veterinary Vaccines Market size at USD 472.06 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Middle East and Africa Veterinary Vaccines Market size to grow at a CAGR of 5.42% reaching a value of USD 648.06 million by 2030. The Middle East and Africa Veterinary Vaccines Market is propelled by rising awareness about animal health, growing livestock population, and the prevalence of infectious diseases. A growing demand for protein-rich food products and the need to enhance agricultural productivity contribute to the market expansion. Government initiatives to control and prevent animal diseases, coupled with advancements in biotechnology, further drive vaccine adoption. Additionally, a surge in companion animal ownership and the emergence of zoonotic diseases underscore the importance of veterinary vaccines, fostering market growth in Middle East and Africa.

Opportunity – Increasing demand for organic and sustainable livestock production

The Middle East and Africa Veterinary Vaccines Market is propelled by the burgeoning demand for organic and sustainable livestock production. As consumers prioritize healthier and ethically sourced animal products, the market experiences a surge in demand for veterinary vaccines that support sustainable farming practices. The shift toward organic livestock production ensures the well-being of animals and also emphasizes the importance of disease prevention, driving the adoption of advanced veterinary vaccines in the region.

Impact of Escalating Geopolitical Tensions on Middle East and Africa Veterinary Vaccines Market

The escalating geopolitical tensions in the Middle East and Africa have added a layer of uncertainty and volatility to the Veterinary Vaccines Market in the region, further compounded by the Israel-Hamas conflict and Russia-Ukraine war. Economic sanctions and geopolitical challenges have created ripple effects across industries, influencing consumer sentiment and purchasing behaviors. In the context of recent tensions between Israel and its neighbors, various industries face potential revenue impacts. However, the Israeli government's strong focus on national security, including biosecurity, highlights the crucial role of the veterinary vaccines sector. Despite broader economic challenges, the market remains essential for preserving animal populations, ensuring food security, and preventing bioterrorism. In navigating these complex dynamics, businesses must adopt agile and responsive veterinary vaccine strategies to address evolving consumer preferences and geopolitical landscape.

Middle East and Africa Veterinary Vaccines Market

Segmental Coverage

Middle East and Africa Veterinary Vaccines Market – By Type

Based on type, Middle East and Africa Veterinary Vaccines Market is divided into Poultry Vaccine, Livestock Vaccines (Bovine Vaccines and Small Ruminant Vaccines) Companion Animal Vaccines (Feline Vaccines and Canine Vaccines), and Aquaculture Vaccine segments. The livestock vaccines segment, encompassing bovine vaccines and small ruminant vaccines segment is the largest in the Middle East and Africa Veterinary Vaccines Market. The segment plays a pivotal role in safeguarding the health of cattle and small ruminants, contributing significantly to the overall veterinary vaccine market in the region. With a focus on livestock health and welfare, these vaccines address the unique needs of bovine and small ruminant populations, reflecting the importance of the agricultural and farming sectors in the Middle East and Africa.

Middle East and Africa Veterinary Vaccines Market – By Technology

By technology, the Middle East and Africa Veterinary Vaccines Market is divided into Live Attenuated Vaccines, Inactivated Vaccines (Toxoid Vaccines and Recombinant Vaccines), and Conjugate Vaccines segments. The inactivated vaccines segment, further categorized into toxoid vaccines and recombinant vaccines segments dominates the market share. The segment involves vaccines that are either deactivated or genetically engineered, offering a wide range of applications in veterinary medicine. Inactivated vaccines are crucial in preventing diseases among animals, and the toxoid and recombinant subcategories highlight the advanced technologies employed for heightened efficacy. The segment's prominence underscores the region's emphasis on innovative veterinary healthcare solutions, contributing significantly to the overall market landscape.

Competitive Landscape

Middle East and Africa Veterinary Vaccines Market is fiercely competitive. Major companies in the market include BIOVAC, Boehringer Ingelheim International GmbH, Ceva, Elanco, Hester Biosciences Limited, Merck & Co., Inc., NEOGEN Corporation, Virbac, and Zoetis Inc. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Middle East and Africa Veterinary Vaccines Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Middle East and Africa Veterinary Vaccines Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Middle East and Africa Veterinary Vaccines Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

200 Pages
1. Research Framework
1.1. Research Objective
1.2. Technology Overview
1.3. Market Segmentation
2. Executive Summary
3. Middle East and Africa Veterinary Vaccines Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.2. Growth Drivers
3.2.2.1. Rising prevalence of animal diseases
3.2.2.2. Growing awareness of animal welfare
3.2.3. Restraints
3.2.3.1. High cost of vaccines
3.2.3.2. Lack of awareness of vaccination benefits
3.2.4. Opportunities
3.2.4.1. Increasing demand for organic and sustainable livestock production
3.2.4.2. Development of new vaccines
3.2.5. Challenges
3.2.5.1. Availability of counterfeit vaccines
3.2.5.2. Lack of cold chain infrastructure
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Middle East and Africa Veterinary Vaccines Market Overview
4.1. Market Size & Forecast, 2019–2030
4.1.1. By Value (USD Million)
4.2. Market Share and Forecast
4.2.1. By Type
4.2.1.1. Poultry Vaccine
4.2.1.2. Livestock Vaccines
4.2.1.2.1. Bovine Vaccines
4.2.1.2.2. Small Ruminant Vaccines
4.2.1.3. Companion Animal Vaccines
4.2.1.3.1. Feline Vaccines
4.2.1.3.2. Canine Vaccines
4.2.1.3.3. Others
4.2.1.4. Aquaculture Vaccine
4.2.1.5. Others
4.2.2. By Technology
4.2.2.1. Live Attenuated Vaccines
4.2.2.2. Inactivated Vaccines
4.2.2.3. Toxoid Vaccines
4.2.2.4. Recombinant Vaccines
4.2.2.5. Conjugate Vaccines
4.2.2.6. Others
4.2.3. By Disease
4.2.3.1. Porcine Disease
4.2.3.2. Poultry Disease
4.2.3.3. Livestock Disease
4.2.3.4. Companion Animal Disease
4.2.3.5. Others
4.2.4. By Distribution Channel
4.2.4.1. Oral Vaccines
4.2.4.2. Injection Vaccines
4.2.4.3. Intranasal Spray Vaccines
4.2.5. By Country
4.2.5.1. Saudi Arabia
4.2.5.2. UAE
4.2.5.3. Qatar
4.2.5.4. Kuwait
4.2.5.5. South Africa
4.2.5.6. Nigeria
4.2.5.7. Algeria
4.2.5.8. Rest of MEA
5. Saudi Arabia Veterinary Vaccines Market
5.1. Market Size & Forecast, 2019–2030
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Type
5.2.2. By Technology
5.2.3. By Disease
5.2.4. By Distribution Channel
6. UAE Veterinary Vaccines Market
6.1. Market Size & Forecast, 2019–2030
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Technology
6.2.3. By Disease
6.2.4. By Distribution Channel
7. Qatar Veterinary Vaccines Market
7.1. Market Size & Forecast, 2019–2030
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Technology
7.2.3. By Disease
7.2.4. By Distribution Channel
8. Kuwait Veterinary Vaccines Market
8.1. Market Size & Forecast, 2019–2030
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Technology
8.2.3. By Disease
8.2.4. By Distribution Channel
9. South Africa Veterinary Vaccines Market
9.1. Market Size & Forecast, 2019–2030
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Technology
9.2.3. By Disease
9.2.4. By Distribution Channel
10. Nigeria Veterinary Vaccines Market
10.1. Market Size & Forecast, 2019–2030
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Technology
10.2.3. By Disease
10.2.4. By Distribution Channel
11. Algeria Veterinary Vaccines Market
11.1. Market Size & Forecast, 2019–2030
11.1.1. By Value (USD Million)
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Technology
11.2.3. By Disease
11.2.4. By Distribution Channel
12. Rest of MEA Veterinary Vaccines Market
12.1. Market Size & Forecast, 2019–2030
12.1.1. By Value (USD Million)
12.2. Market Share & Forecast
12.2.1. By Type
12.2.2. By Technology
12.2.3. By Disease
12.2.4. By Distribution Channel
13. Competitive Landscape
13.1. List of Key Players and Their Offerings
13.2. Middle East and Africa Veterinary Vaccines Market Share Analysis, 2023
13.3. Competitive Benchmarking, By Operating Parameters
13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
14. Impact of Escalating Geopolitical Tensions on Middle East and Africa Veterinary Vaccines Market
15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
15.1. BIOVAC
15.2. Boehringer Ingelheim International GmbH
15.3. Ceva
15.4. Elanco
15.5. Hester Biosciences Limited
15.6. Merck & Co., Inc.
15.7. NEOGEN Corporation
15.8. Virbac
15.9. Zoetis Inc.
15.10. Other Prominent Players
16. Key Strategic Recommendations
17. Research Methodology
17.1. Qualitative Research
17.1.1. Primary & Secondary Research
17.2. Quantitative Research
17.3. Market Breakdown & Data Triangulation
17.3.1. Secondary Research
17.3.2. Primary Research
17.4. Breakdown of Primary Research Respondents, By Region
17.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
List of Figures
Figure 1 Middle East and Africa Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Figure 2 Middle East and Africa Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
Figure 3 Middle East and Africa Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
Figure 4 Middle East and Africa Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
Figure 5 Middle East and Africa Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
Figure 6 Middle East and Africa Veterinary Vaccines Market Share, By Country, By Value, 2019–2030
Figure 7 Saudi Arabia Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Figure 8 Saudi Arabia Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
Figure 9 Saudi Arabia Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
Figure 10 Saudi Arabia Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
Figure 11 Saudi Arabia Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
Figure 12 UAE Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Figure 13 UAE Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
Figure 14 UAE Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
Figure 15 UAE Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
Figure 16 UAE Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
Figure 17 Qatar Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Figure 18 Qatar Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
Figure 19 Qatar Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
Figure 20 Qatar Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
Figure 21 Qatar Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
Figure 22 Kuwait Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Figure 23 Kuwait Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
Figure 24 Kuwait Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
Figure 25 Kuwait Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
Figure 26 Kuwait Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
Figure 27 South Africa Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Figure 28 South Africa Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
Figure 29 South Africa Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
Figure 30 South Africa Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
Figure 31 South Africa Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
Figure 32 Nigeria Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Figure 33 Nigeria Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
Figure 34 Nigeria Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
Figure 35 Nigeria Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
Figure 36 Nigeria Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
Figure 37 Algeria Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Figure 38 Algeria Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
Figure 39 Algeria Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
Figure 40 Algeria Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
Figure 41 Algeria Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
Figure 42 Rest of MEA Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Figure 43 Rest of MEA Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
Figure 44 Rest of MEA Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
Figure 45 Rest of MEA Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
Figure 46 Rest of MEA Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
List of Tables
Table 1 Middle East and Africa Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Table 2 Middle East and Africa Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
Table 3 Middle East and Africa Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
Table 4 Middle East and Africa Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
Table 5 Middle East and Africa Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
Table 6 Middle East and Africa Veterinary Vaccines Market Size, By Country, By Value, 2019–2030
Table 7 Saudi Arabia Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Table 8 Saudi Arabia Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
Table 9 Saudi Arabia Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
Table 10 Saudi Arabia Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
Table 11 Saudi Arabia Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
Table 12 UAE Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Table 13 UAE Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
Table 14 UAE Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
Table 15 UAE Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
Table 16 UAE Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
Table 17 Qatar Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Table 18 Qatar Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
Table 19 Qatar Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
Table 20 Qatar Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
Table 21 Qatar Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
Table 22 Kuwait Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Table 23 Kuwait Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
Table 24 Kuwait Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
Table 25 Kuwait Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
Table 26 Kuwait Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
Table 27 South Africa Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Table 28 South Africa Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
Table 29 South Africa Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
Table 30 South Africa Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
Table 31 South Africa Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
Table 32 Nigeria Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Table 33 Nigeria Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
Table 34 Nigeria Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
Table 35 Nigeria Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
Table 36 Nigeria Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
Table 37 Algeria Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Table 38 Algeria Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
Table 39 Algeria Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
Table 40 Algeria Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
Table 41 Algeria Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
Table 42 Rest of MEA Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
Table 43 Rest of MEA Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
Table 44 Rest of MEA Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
Table 45 Rest of MEA Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
Table 46 Rest of MEA Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
Table 47 BIOVAC Company Overview
Table 48 BIOVAC Financial Overview
Table 49 Boehringer Ingelheim International GmbH Company Overview
Table 50 Boehringer Ingelheim International GmbH Financial Overview
Table 51 Ceva Company Overview
Table 52 Ceva Financial Overview
Table 53 Elanco Company Overview
Table 54 Elanco Financial Overview
Table 55 Hester Biosciences Limited Company Overview
Table 56 Hester Biosciences Limited Financial Overview
Table 57 Merck & Co., Inc. Company Overview
Table 58 Merck & Co., Inc. Financial Overview
Table 59 NEOGEN Corporation Company Overview
Table 60 NEOGEN Corporation Financial Overview
Table 61 Virbac Company Overview
Table 62 Virbac Financial Overview
Table 63 Zoetis Inc. Company Overview
Table 64 Zoetis Inc. Financial Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us